Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Neoplasms 2Colorectal Neoplasms 2Advanced Solid Tumors 2Sexual Dysfunction, Physiological 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non Small Lung Cancer 1Neoplasm Metastasis 1Mesothelioma 1Fallopian Tube Neoplasms 1Eunuchism 1Erectile Dysfunction 1Endometrial Neoplasms 1Brain Neoplasms 1Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation 1

Interventions

Blood Specimen Collection 38pembrolizumab 36Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 18Exercise 17Carboplatin 16Nivolumab 15atezolizumab 14Cisplatin 14Drug Therapy 13Paclitaxel 12Fluorouracil 12Cyclophosphamide 12Cetuximab 12Trastuzumab 10Leucovorin 10Docetaxel 10Dexamethasone 10Pemetrexed 9Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × sotorasib × Clear all
NCT05920356 2026-06-04

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Amgen

Phase 3 Recruiting
750 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06252649 2026-04-24

CodeBreaK 301

Amgen

Phase 3 Recruiting
450 enrolled
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡